Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Assessment of the Prophylactic Use of AneuFix at the Time of EVAR Implantation

NCT04307992 is registered in ClinicalTrials.gov with TripleMed B.V. as lead sponsor.

NCT NCT04307992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04307992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Assessment of the Prophylactic Use of AneuFix at the Time of EVAR Implantation
Lead sponsor
TripleMed B.V.
Phase
Not applicable
Overall status
Unknown status
Start date
February 15, 2022
Completion date
December 31, 2025
Enrollment
5 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal aortic aneurysm, endoleak